CXMT's $10 Billion China IPO Is a Poisoned Chalice

When an initial public offering is too exciting, markets worry that it will suck out all the oxygen. SpaceX’s post-listing slump has soured the mood toward hot IPOs in the US. Now it’s China’s turn to tame the tempest.